Analysis of Epidemiological Data and Risk Factors for Helicobacter pylori Infection Among Children and Adolescents in Hainan Province - Scorecard - DentalSpire

Analysis of Epidemiological Data and Risk Factors for Helicobacter pylori Infection Among Children and Adolescents in Hainan Province

  • By

  • Yuliang Huang

  • Yanting Lv

  • Xianfeng Huang

  • Daya Zhang

  • Chen Chen

  • Shuo Zhou

  • Xiaodong Zhang

  • Shiju Chen

  • Da Li

  • Fengjiao Mao

  • Shimei Huang

  • Fan Zeng

  • Runxiang Chen

  • Yiping Du

  • Runyu Chen

  • Ying Mo

  • Qicen Yao

  • Fei Zheng

  • Chuni Han

  • Yuehong Jiang

  • Yunqian Xie

  • Feihu Bai

  • January 19, 2026

  • 0 min

Share

Clinical Scorecard: Analysis of Epidemiological Data and Risk Factors for Helicobacter pylori Infection Among Children and Adolescents in Hainan Province

At a Glance

CategoryDetail
ConditionHelicobacter pylori infection
Key MechanismsColonization of gastric mucosa by microaerophilic, Gram-negative, spiral-shaped bacterium with helical morphology and flagella enabling survival in acidic stomach environment
Target PopulationChildren and adolescents aged 6–17 years in Hainan Province, China
Care SettingSchool-based epidemiological survey with clinical testing and questionnaire assessment

Key Highlights

  • H. pylori is a Group I carcinogen linked to chronic gastritis, peptic ulcer, gastric cancer, MALT lymphoma, GERD, and functional dyspepsia.
  • Global prevalence remains high in children and adolescents, especially in low socioeconomic and poor sanitation areas; adolescent prevalence in China reported at 24.89%.
  • Traditional PPI-based triple therapy efficacy is declining below 80% due to increasing clarithromycin resistance.

Guideline-Based Recommendations

Diagnosis

  • Use C13 urea breath test (C13-UBT) for non-invasive detection of H. pylori infection.

Management

  • Standard treatment includes PPI-based triple therapy combining PPI, clarithromycin, and amoxicillin or metronidazole.
  • Consider antibiotic resistance patterns, especially clarithromycin resistance mutations (A2143G, A2144G), when selecting therapy.

Monitoring & Follow-up

  • Monitor treatment efficacy due to declining eradication rates linked to antibiotic resistance.

Risks

  • Risk factors include close family contact, poor sanitation, high population density, and lower socioeconomic status.
  • Avoid recent use of antibiotics, PPIs, or bismuth agents before diagnostic testing to prevent false negatives.

Patient & Prescribing Data

Children and adolescents aged 6–17 years attending schools in Hainan Province

High clarithromycin resistance reduces efficacy of standard triple therapy; tailored treatment strategies may be necessary.

Clinical Best Practices

  • Obtain informed consent from parents and participants prior to testing and data collection.
  • Use stratified sampling to ensure representative epidemiological data across geographic and socioeconomic groups.
  • Administer questionnaires with parental assistance for children under 12 to ensure data accuracy.
  • Exclude patients with recent antibiotic, PPI, or bismuth use to avoid diagnostic interference.
  • Consider regional antibiotic resistance patterns when selecting eradication regimens.

References

Original Source(s)

Related Content